These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 17581166)

  • 1. Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch?
    Lee E; Redman M; Burgess G; Win N
    Transfusion; 2007 Jul; 47(7):1290-5. PubMed ID: 17581166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic crossmatching.
    Arslan O
    Transfus Med Rev; 2006 Jan; 20(1):75-9. PubMed ID: 16373190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization.
    Dinardo CL; Bonifácio SL; Mendrone A
    Immunohematology; 2014; 30(1):1-5. PubMed ID: 25238242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA: ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS.
    Ndahimana E; Gothot A; Gérard C; Senyana F; R'Zik S; Mukabayire O; Mutesa L
    East Afr Med J; 2013 Apr; 90(4):124-9. PubMed ID: 26866096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-stage papain-indirect antiglobulin test and LISS direct agglutination are not appropriate for pretransfusion screening for unexpected antibodies.
    Pereira A; Mazzara R; Gelabert A; Castillo R
    Haematologica; 1991; 76(6):475-8. PubMed ID: 1820984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serologic markers related to red blood cell autoantibodies production after red blood cell transfusion-severe autoimmune hemolytic anemia occurring after transfusion and alloimmunization: successful treatment with rituximab.
    Sigler E; Shvidel L; Yahalom V; Berrebi A; Shtalrid M
    Transfusion; 2009 Jul; 49(7):1370-4. PubMed ID: 19374728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted?
    Judd WJ; Fullen DR; Steiner EA; Davenport RD; Knafl PC
    Transfusion; 1999 Mar; 39(3):295-9. PubMed ID: 10204593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically significant red cell alloantibodies in patients with warm autoimmune hemolytic anemia.
    Haspl ZH; Tomicić M; Grgicević D
    Acta Med Croatica; 2001; 55(4-5):149-52. PubMed ID: 12398016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):273-83. PubMed ID: 8885158
    [No Abstract]   [Full Text] [Related]  

  • 10. Cut-off value of red-blood-cell-bound IgG for the diagnosis of Coombs-negative autoimmune hemolytic anemia.
    Kamesaki T; Oyamada T; Omine M; Ozawa K; Kajii E
    Am J Hematol; 2009 Feb; 84(2):98-101. PubMed ID: 19105232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3 new antibody detection tests. A comparative study].
    Mempel W; Alraun K; Leeping M; Kirschner M; Reiser H; Heim MU
    Beitr Infusionsther; 1990; 26():362-6. PubMed ID: 1703872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.
    Pinkerton PH; Coovadia AS; Goldstein J
    Transfusion; 1992; 32(9):814-7. PubMed ID: 1471244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Observation of antibody screen of patients with autoimmune hemolytic anemia].
    Yang SM; Lan JC; Hu LY; Lou HQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):849-51. PubMed ID: 15631676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch.
    Shulman IA
    Arch Pathol Lab Med; 1990 Apr; 114(4):412-4. PubMed ID: 2322101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flow cytometry analysis of IGG subclasses of auto- and alloantibodies in autoimmune hemolytic anemia and hemolytic disease of the newborn].
    Lynen R; Neuhaus R; Simson G; Riggert J; Köhler M
    Beitr Infusionsther Transfusionsmed; 1994; 32():203-7. PubMed ID: 9480088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies.
    Weisbach V; Kohnhäuser T; Zimmermann R; Ringwald J; Strasser E; Zingsem J; Eckstein R
    Transfus Med; 2006 Aug; 16(4):276-84. PubMed ID: 16879156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems associated with compatibility testing for patients with autoimmune hemolytic anemia.
    Garratty G
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():76-9. PubMed ID: 7886613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety in transfusion practice. Is it safe to eliminate the major crossmatch for selected patients?
    Shulman IA; Kent D
    Arch Pathol Lab Med; 1989 Mar; 113(3):270-2. PubMed ID: 2919957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Crossmatching for vital indications].
    Schönitzer D
    Infusionsther Klin Ernahr; 1983 Feb; 10(1):4-10. PubMed ID: 6840830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology consultation on electronic crossmatch.
    Mazepa MA; Raval JS; Park YA;
    Am J Clin Pathol; 2014 May; 141(5):618-24. PubMed ID: 24713731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.